Description: NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Home Page: www.neuropace.com
NPCE Technical Analysis
455 North Bernardo Avenue
Mountain View,
CA
94043
United States
Phone:
650 237 2700
Officers
| Name | Title |
|---|---|
| Mr. Michael L. Favet | Pres, CEO & Director |
| Ms. Irina Ridley | Gen. Counsel & Corp. Sec. |
| Dr. Martha J. Morrell | Chief Medical Officer |
| Ms. Rebecca L. Kuhn | CFO, VP of Fin. & Admin. and Assistant Sec. |
| Ms. Chi Nguyen | VP of Marketing |
| Mr. Mark S. Saxton | VP of Sales |
| Ms. Irene Thomas | VP of HR |
| Mr. Andre G. Marquette | Chief Commercial Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0097 |
| Price-to-Sales TTM: | 0.9055 |
| IPO Date: | 2021-04-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 174 |